Navigation Links
International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
Date:9/27/2007

SINGAPORE, Sept. 27 /Xinhua-PRNewswire/ -- NeuroAid(TM) is the first natural compound to be studied in a large clinical trial focused on stroke recovery starting in the acute stage.

The CHIMES study is a multi-center double-blind placebo-controlled randomized trial to evaluate the efficacy of NeuroAid(TM) in reducing neurological deficit and improving independence in patients in rehabilitation, with treatment starting within 48 hours of a stroke. Already studied in a rehabilitation setting with initiation of treatment within 14 days of stroke incidence, NeuroAid(TM) will now be evaluated when administered in the acute stage, with periodic assessments for three months. The study will begin enrollment of 1,100 patients in early October 2007 at several hospitals in Singapore, followed by hospitals in the Philippines and in Thailand.

The study will be conducted by CHIMES Society, an international partnership of Key Opinion Leaders in stroke whose objective is to establish new stroke treatments.

Professor Marie-Germaine Bousser, Head of the Neurology Department at Lariboisiere Hospital in Paris, France and member of the Council of the American Stroke Association, commented, ''Recent drug trials in the acute treatment of stroke have unfortunately all been negative. It is thus very exciting to take a completely new approach and to scientifically test in different populations a compound that has long been used in Traditional Chinese Medicine.''

David Picard, CEO of Moleac, the Singapore/Biopolis-based global biopharmaceutical company that develops and markets NeuroAid(TM) outside of China, said: ''We are delighted at the interest NeuroAid(TM) has generated in the medical community worldwide. Over 200,000 patients in China alone are using NeuroAid(TM) every year, and patient feedback from other countries is very positive. Our next milestone is to generate clinical data in the acute phase, with studies that meet the standards of European and U.S
'/>"/>

SOURCE Moleac
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/ctd7zx/europe ) has announced the addition of ... (2014 - 2019)" report to their offering. ... Germany . This is followed by UK and ... Poland are the fastest growing segments. ... the basis of Product (Film Screen, Digital, 3D, Analog Systems, ...
(Date:6/2/2015)... Texas , June 2, 2015 ... report defines and segments the concerned market with ... valued at $261.8 million in 2014, and is ... a CAGR of 19.3% from 2014 to 2019. ... America Mannequin-Based Simulation Market for an analysis of ...
(Date:6/2/2015)... 2015 Intarcia Therapeutics, Inc. today ... its recently announced synthetic royalty / equity convert financing, ... have purchased Convertible Limited Recourse Notes from Intarcia and ... of any future global net sales of ITCA 650 ... also have the option, commencing upon U.S. regulatory approval ...
Breaking Medicine Technology:Europe Mammography Market Report 2014-2019 - Growth, Trends And Forecasts 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 2North America Mannequin-Based Simulation Market is Expected to Reach $632.5 Million by 2019, at a CAGR of 19.3% From 2014 to 2019 3Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 2Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million 3
...  Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... results on Thursday, April 26, 2012, before the U.S. financial ... 8:30 AM EDT that day. Live audio ... link to the webcast may be accessed from the ,Events ...
... Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) ... subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to ... DS Healthcare Limited to assist in introducing Clotamin to ... the agreement, DS Healthcare will evaluate the Clotamin formulation ...
Cached Medicine Technology:Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries 2
(Date:6/2/2015)... 02, 2015 Erbelli’s Gourmet Pizzeria, Italian ... promote its handmade gourmet pizzas and calzones, fresh wraps, ... website is new, the recipes are not—they have been ... main feature of the site is the menu, which ... descriptions of all the items. You can order directly ...
(Date:6/2/2015)... Claflin Medical Equipment , a ... acquisition of RSI Equipment, Inc ., a ... 2015. , With CME’s recent merger of Hospital ... three premier organizations which specialize in the procurement and ... By combining forces, they now cover the entire country ...
(Date:6/2/2015)... ZOOM+, the Portland-based health innovator of on-demand ... today the opening of its on-demand ZOOM+Smile studio. ZOOM+Smile ... complete dental exam, cleaning and whitening in 57 minutes, ... ZOOM+ services, ZOOM+Smile can be scheduled by mobile phone ... be as inviting as your favorite coffee shop?” said ...
(Date:6/2/2015)... Acara Partners has seen a spike in demand for ... as is now required by recent Google search algorithm changes. ... several new clients in the medical aesthetics vertical, are anxious ... meet Google’s new requirements,” commented Fran Acunzo, CEO of Acara ... education, non-profits, and the business world.” , Back in ...
(Date:6/2/2015)... Vancouver, BC (PRWEB) June 02, 2015 ... to announce the opening of Surrey’s first ... cities and boasts a diverse, young community, ... communities. http://www.theglobeandmail.com/news/british-columbia/four-reasons-bcs-fastest-growing-city-is-a-political-powerhouse/article21408253/ , Until now ... have had to come into Vancouver ...
Breaking Medicine News(10 mins):Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Claflin Medical Equipment (CME) Announces Acquisition of RSI Equipment, Inc. 2Health News:ZOOM+ Opens Its First On-Demand ZOOM+Smile Studio and Reinvents the Dental Exam 2Health News:Acara Partners Expands Website and Digital Offerings 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2
... Vendome Group, publishers of HEALTHCARE DESIGN and ... The Center for Health Design (CHD), a nonprofit research, ... development of a 2-day educational track for HEALTHCARE DESIGN.09 ... engineering technologies of healthcare facilities. , , The ...
... one-third of Americans use complementary or alternative medicine (CAM). ... to, rather than instead of, a conventional medical regimen. ... place at the point of care, "The ACP Evidence-Based ... resource for clinicians and patients. "The book is ...
... ... is now a featured expert on searchvitaminsupplements.com, a new informational Web site devoted to ... , ... (PRWEB) July 8, 2009 -- Dr. Stephen Sinatra , a board-certified cardiologist, nutritionist, ...
... Gold,s Gym, the world,s leading authority on health and ... epidemic by once again supporting the American Diabetes Association,s Tour ... company is the Tour de Cure,s top national fundraiser and, ... raised more than $350,000. , , Since Gold,s ...
... N.Y., July 8 VirtualScopics, Inc. (Nasdaq: VSCP ... announced revenues for the second quarter ended June 30, 2009 ... the comparable period in 2008. , , "We ... growth," stated Jeff Markin, President and Chief Executive Officer of ...
... been presented with the prestigious Amethyst Award from the Ontario ... 2009 from the Premier of Ontario, Dalton McGuinty, in recognition ... combating air pollution in Canada and the United States. ... Air Quality, Atmosphere & Health and has co-authored ...
Cached Medicine News:Health News:HEALTHCARE DESIGN.09 Adds a New Construction and Engineering Track 2Health News:HEALTHCARE DESIGN.09 Adds a New Construction and Engineering Track 3Health News:Evidence-based information about complementary and alternative medicine treatments now available 2Health News:Board-Certified Cardiologist Dr. Stephen Sinatra Featured on Searchvitaminsupplements.com 2Health News:Team Gold's Gym Continues to Lead the National Fight Against Diabetes 2Health News:Team Gold's Gym Continues to Lead the National Fight Against Diabetes 3Health News:VirtualScopics Reports Record Revenue 2
... Vessel Dissector has application for use in ... the extraperitoneal spaces such as the retroperitoneal, ... be used in surgical procedures requiring dissection ... harvesting of a quality conduit through a ...
... The Thoratec VAD System includes three ... Drive Console or TLC-II Portable Driver. This ... when the natural heart, with conventional therapy, ... perfuse vital organs. To accomplish support, blood ...
... two distinct polyethylene glycol polymers that combine to ... to chemically bond to each other, as well ... material forms a flexible, watertight seal that remains ... withstand arterial pressure. It is completely resorbed by ...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with...
Medicine Products: